T2 Biosystems Inc (LTS:0A57)
$ 0.3401 0.0048 (1.37%) Market Cap: 7.26 Mil Enterprise Value: 24.12 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 29/100

Q1 2020 T2 Biosystems Inc Earnings Call Transcript

May 05, 2020 / 08:30PM GMT
Operator

Good day, everyone. Welcome to today's T2 Biosystems First Quarter 2020 Earnings Conference Call. Today's call is being recorded.

At this time, I'd like to turn things over to Mr. Philip Taylor, Investor Relations. Please go ahead, sir.

Philip Taylor
Gilmartin Group LLC - Associate

Thank you, operator. Thank you for joining us for the T2 Biosystems First Quarter 2020 Financial Results Conference Call. I would like to remind everyone that comments made by management today and answers to questions today will include forward-looking statements. Those include statements related to T2 Biosystems' future financial and operating results and plans for developing and marketing new products.

Forward-looking statements are based on estimates and assumptions as of today and are subject to the risks and uncertainties that may cause actual results to differ materially from those expressed or implied by these statements, including the risks and uncertainties described in T2 Biosystems' annual report on Form 10-K filed with the SEC March 16, 2020 and other

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot